You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CCCC Sale Disclosure
Adams Kendra · SEC Form 4 · Filed Nov 13, 2026
Sale
Calculated transaction value
$122.49K
Adams Kendra Chief Financial Officer
CCCC
C4 Therapeutics
CCCC
Transaction date
Nov 12, 2026
Public filing date
Nov 13, 2026
Filing lag
Filed 1 day later
CCCC daily price context
Close on/before transaction
$2.77
Nov 12, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 45,173 shares @ $2.71
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001470831-26-001003
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$122.49K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| C4 Therapeutics, Inc. CCCC Current | Sale | Nov 12, 2026 | $122.49K |